References
- Rowlands RJ, Michaud V, Heath L, et al. African swine fever virus isolate, Georgia, 2007. Emerg Infect Dis [Internet]. 2008;14:1870–1874. Available from: https://pubmed.ncbi.nlm.nih.gov/19046509.
- Kolbasov D, Titov I, Tsybanov S, et al. African Swine Fever Virus, Siberia, Russia, 2017. Emerg Infect Dis [Internet]. 2018;24:796–798. Available from: https://pubmed.ncbi.nlm.nih.gov/29553323.
- World Organisation for Animal Health. African Swine Fever Global Situation [Internet]. OIE WAHIS. 2022 [cited 2022 Apr 10]. Available from: https://www.oie.int/en/disease/african-swine-fever/#ui-id-2.
- Andrés G, Charro D, Matamoros T, et al. The cryo-EM structure of African swine fever virus unravels a unique architecture comprising two icosahedral protein capsids and two lipoprotein membranes. J Biol Chem. [Internet]. 2020;295:1, [cited 2022 Jun 29]; Available from: /pmc/articles/PMC6952596/.
- Nurmoja I, Petrov A, Breidenstein C, et al. Biological characterization of African swine fever virus genotype II strains from north-eastern Estonia in European wild boar. Transboundary Emerging Dis [Internet]. 2017;64:2034–2041. doi:10.1111/tbed.12614.
- Sun E, Huang L, Zhang X, et al. Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection. Emerging Microbes Infect [Internet]. 2021;10:2183–2193. doi:10.1080/22221751.2021.1999779.
- Rock DL. Thoughts on African swine fever vaccines. Viruses. 2021;13.
- Wang T, Luo R, Sun Y, et al. Current efforts towards safe and effective live attenuated vaccines against African swine fever: challenges and prospects. Infect Dis Poverty [Internet]. 2021;10, [cited 2022 Apr 1]. Available from: /pmc/articles/PMC8702042/.
- Sang H, Miller G, Lokhandwala S, et al. Progress Toward Development of Effective and Safe African Swine Fever Virus Vaccines. Front Vet Sci [Internet]. 2020;7:1–9. [cited 2022 Apr 1]; Available from: /pmc/articles/PMC7047163/.
- Dixon LK, Stahl K, Jori F, et al. African Swine Fever Epidemiology and Control. Annu Rev Anim Biosci [Internet]. 2020;8:221–246. doi:10.1146/annurev-animal-021419-083741.
- Arias M, de la Torre A, Dixon L, et al. Approaches and Perspectives for Development of African Swine Fever Virus Vaccines. Vaccines (Basel) [Internet]. 2017;5:35, Available from: https://pubmed.ncbi.nlm.nih.gov/28991171.
- Escribano JM, Galindo I, Alonso C. Antibody-mediated neutralization of African swine fever virus: myths and facts. Virus Res. 2013;173:101–109.
- Ruiz-Gonzalvo F, Rodríguez F, Escribano JM. Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus. Virology. 1996;218:285–289.
- Malogolovkin A, Burmakina G, Tulman ER, et al. African swine fever virus CD2v and C-type lectin gene loci mediate serological specificity. J Gen Virol [Internet]. 2015;96:866–873. Available from: https://www.microbiologyresearch.org/content/journal/jgv/10.1099jgv.0.000024.
- Burmakina G, Malogolovkin A, Tulman ER, et al. Identification of T-cell epitopes in African swine fever virus CD2v and C-type lectin proteins. J Gen Virol [Internet]. 2019;100:259–265. Available from: https://www.microbiologyresearch.org/content/journal/jgv/10.1099jgv.0.001195.
- Oura CAL, Denyer MS, Takamatsu H, et al. In vivo depletion of CD8+ T lymphocytes abrogates protective immunity to African swine fever virus. J Gen Virol. 2005;86:2445–2450.
- Barasona JA, Gallardo C, Cadenas-Fernández E, et al. First Oral Vaccination of Eurasian Wild Boar Against African Swine Fever Virus Genotype II. Front Vet Sci [Internet]. 2019;6:137, [cited 2022 Apr 6]; Available from: http://www.ncbi.nlm.nih.gov/pubmed/31106218.
- Leitão A, Cartaxeiro C, Coelho R, et al. The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J Gen Virol [Internet]. 2001;82:513–523. [cited 2022 Mar 21];Available from: https://pubmed.ncbi.nlm.nih.gov/11172092/.
- Takamatsu H-H, Denyer MS, Lacasta A, et al. Cellular immunity in ASFV responses. Virus Res. 2013;173:110–121.
- Zsak L, Onisk D, Afonso CL, et al. Virulent African Swine Fever Virus Isolates Are Neutralized by Swine Immune Serum and by Monoclonal Antibodies Recognizing a 72-kDa Viral Protein. Virology [Internet]. 1993;196:596–602. Available from: https://www.sciencedirect.com/science/article/pii/S0042682283715151.
- Alonso F, Domínguez J, Viñuela E, et al. African swine fever virus-specific cytotoxic T lymphocytes recognize the 32 kDa immediate early protein (vp32). Virus Res. 1997;49:123–130.
- Schäfer A, Zani L, Pikalo J, et al. T-cell responses in domestic pigs and wild boar upon infection with the moderately virulent African swine fever virus strain ‘Estonia2014.’. Transboundary Emerging Dis [Internet]. 2021; doi:10.1111/tbed.14048.
- Hühr J, Schäfer A, Schwaiger T, et al. Impaired T-cell responses in domestic pigs and wild boar upon infection with a highly virulent African swine fever virus strain. Transboundary Emerging Dis [Internet]. 2020;67:3016–3032. doi:10.1111/tbed.13678.
- Schäfer A, Hühr J, Schwaiger T, et al. Porcine Invariant Natural Killer T Cells: Functional Profiling and Dynamics in Steady State and Viral Infections. Front Immunol. 2019;10:1380.
- Jenson JS, Childerstone A, Takamatsu H-H, et al. The cellular immune recognition of proteins expressed by an African swine fever virus random genomic library. J Immunol Methods [Internet]. 2000;242:33–42. Available from: https://www.sciencedirect.com/science/article/pii/S0022175900002222.
- Leitão A, Malur A, Cartaxeiro C, et al. Bacterial lipoprotein based expression vectors as tools for the characterisation of African swine fever virus (ASFV) antigens. Arch Virol. 2000;145:1639–1657.
- Leitão A, Malur A, Cornelis P, et al. Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system. J Virol Methods [Internet]. 1998;75:113–119. Available from: https://www.sciencedirect.com/science/article/pii/S0166093498001050.
- Argilaguet JM, Pérez-Martín E, López S, et al. BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus. Antiviral Research [Internet]. 2013;98:61–65. Available from: https://www.sciencedirect.com/science/article/pii/S0166354213000417.
- Argilaguet JM, Pérez-Martín E, Nofrarías M, et al. DNA Vaccination Partially Protects against African Swine Fever Virus Lethal Challenge in the Absence of Antibodies. PLOS ONE [Internet]. 2012;7:e40942), doi:10.1371/journal.pone.0040942.
- Goatley LC, Reis AL, Portugal R, et al. A pool of eight virally vectored African swine fever antigens protect pigs against fatal disease. Vaccines (Basel). 2020;8:1–25.
- Netherton CL, Goatley LC, Reis AL, et al. Identification and immunogenicity of African swine fever virus antigens. Front Immunol [Internet]. 2019;10:1318, [cited 2022 Mar 23]; Available from: /pmc/articles/PMC6593957/.
- Schäfer A, Franzoni G, Netherton CL, et al. Adaptive Cellular Immunity against African Swine Fever Virus Infections. Pathogens. 2022;11:274, [Internet]. 2022 [cited 2022 Jun 30];11:274. Available from: https://www.mdpi.com/2076-0817/11/2/274/htm.
- Blome S, Gabriel C, Beer M. Modern adjuvants do not enhance the efficacy of an inactivated African swine fever virus vaccine preparation. Vaccine. 2014;32:3879–3882.
- Cadenas-Fernández E, Sánchez-Vizcaíno JM, van den Born E, et al. High Doses of Inactivated African Swine Fever Virus Are Safe, but Do Not Confer Protection against a Virulent Challenge. Vaccines (Basel). 2021;9:242.
- Vogt W. Researchers turn to proven process for ASF vaccine development. FarmProgress [Internet]. 2021; Available from: https://www.farmprogress.com/animal-health/researchers-turn-proven-process-asf-vaccine-development.
- Gómez-Puertas P, Rodríguez F, Oviedo JM, et al. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response. Virology. 1998;243:461–471.
- Barderas MG, Rodríguez F, Gómez-Puertas P, et al. Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins. Arch Virol [Internet]. 2001;146:1681–1691. [cited 2022 Mar 28];Available from: https://pubmed.ncbi.nlm.nih.gov/11699955/.
- Neilan JG, Zsak L, Lu Z, et al. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection. Virology. 2004;319:337–342.
- Argilaguet JM, Pérez-Martín E, Gallardo C, et al. Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells. Vaccine. 2011;29:5379–5385.
- Lacasta A, Ballester M, Monteagudo PL, et al. Expression library immunization can confer protection against lethal challenge with African swine fever virus. J Virol [Internet]. 2014;88:13322–13332. Available from: https://pubmed.ncbi.nlm.nih.gov/25210179.
- Lokhandwala S, Petrovan V, Popescu L, et al. Adenovirus-vectored African Swine Fever Virus antigen cocktails are immunogenic but not protective against intranasal challenge with Georgia 2007/1 isolate. Vet Microbiol [Internet]. 2019;235:10–20. [cited 2022 Mar 23];Available from: https://pubmed.ncbi.nlm.nih.gov/31282366/.
- Murgia MV, Mogler M, Certoma A, et al. Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus. Arch Virol. 2019;164:359–370.
- Jancovich JK, Chapman D, Hansen DT, et al. Immunization of pigs by DNA prime and recombinant vaccinia virus boost to identify and rank African swine fever virus immunogenic and protective proteins. J Virol. 2018;92:e02219–17.
- Balysheva VI, Prudnikova EYU, Galnbek TV, et al. Immunological properties of attenuated variants of African swine fever virus isolated in the Russian Federation. Russian Agric Sci. 2015;41:2, [Internet]. 2015 [cited 2022 Mar 31];41:178–182. Available from: https://link.springer.com/article/10.3103S1068367415020056.
- Krug PW, Holinka LG, O’Donnell V, et al. The progressive adaptation of a georgian isolate of African swine fever virus to vero cells leads to a gradual attenuation of virulence in swine corresponding to major modifications of the viral genome. J Virol [Internet]. 2015;89:2324–2332. [cited 2022 Mar 31]; Available from: https://pubmed.ncbi.nlm.nih.gov/25505073/.
- Lacasta A, Monteagudo PL, Jiménez-Marín Á, et al. Live attenuated African swine fever viruses as ideal tools to dissect the mechanisms involved in viral pathogenesis and immune protection. Vet Res [Internet]. 2015;46:135), doi:10.1186/s13567-015-0275-z.
- Gallardo C, Soler A, Nieto R, et al. Protection of European domestic pigs from Armenia Virulent African Swine fever virus by experimental immunisation using the attenuated and non-haemadsorbing African Swine fever virus isolate ASF/NH/P68. IX International Congress of Veterinary Virology (ESVV). Madrid, Spain; 2012.
- Sánchez-Cordón PJ, Chapman D, Jabbar T, et al. Different routes and doses influence protection in pigs immunised with the naturally attenuated African swine fever virus isolate OURT88/3. Antiviral Res [Internet]. 2017;138:1, [cited 2022 Mar 31]; Available from: /pmc/articles/PMC5245086/.
- Portugal R, Coelho J, Höper D, et al. Related strains of African swine fever virus with different virulence: Genome comparison and analysis. J Gen Virol [Internet]. 2015;96:408–419. [cited 2022 Mar 31]; Available from: https://www.microbiologyresearch.org/content/journal/jgv/10.1099vir.0.070508-0.
- Gallardo C, Soler A, Rodze I, et al. Attenuated and non-haemadsorbing (non-HAD) genotype II African swine fever virus (ASFV) isolated in Europe, Latvia 2017. Transbound Emerg Dis [Internet]. 2019;66:1399–1404. [cited 2022 Mar 31]; Available from: https://pubmed.ncbi.nlm.nih.gov/30667598/.
- Arias M, de La Torre A, Dixon L, et al. Blueprint and Roadmap (BRMP) on the possible development of an African Swine Fever (ASF) vaccine [Internet]. Brussels; 2017 [cited 2022 Apr 1]. Available from: https://ec.europa.eu/food/system/files/2017-02/cff_animal_vet-progs_asf_blue-print-road-map.pdf.
- Ramirez-Medina E, Vuono E, Rai A, et al. Deletion of E184L, a Putative DIVA Target from the Pandemic Strain of African Swine Fever Virus, Produces a Reduction in Virulence and Protection against Virulent Challenge. J Virol [Internet]. 2022;96, [cited 2022 Mar 21]; Available from: https://pubmed.ncbi.nlm.nih.gov/34668772/.
- Sang H, Miller G, Lokhandwala S, et al. Progress Toward Development of Effective and Safe African Swine Fever Virus Vaccines. Front Vet Sci [Internet]. 2020;7:84, [cited 2022 Apr 1]; Available from: /pmc/articles/PMC7047163/.
- Lopez E, Heerden Jv, Bosch-Camós L, et al. Live Attenuated African Swine Fever Viruses as Ideal Tools to Dissect the Mechanisms Involved in Cross-Protection. Viruses [Internet]. 2020 [cited 2022 Apr 1];12. Available from: https://pubmed.ncbi.nlm.nih.gov/33371460/.
- Monteagudo PL, Lacasta A, López E, et al. BA71ΔCD2: a New Recombinant Live Attenuated African Swine Fever Virus with Cross-Protective Capabilities. J Virol [Internet]. 2017;91, [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/28814514/.
- Borca MV, O’Donnell V, Holinka LG, et al. Deletion of CD2-like gene from the genome of African swine fever virus strain Georgia does not attenuate virulence in swine. Scientific Reports [Internet]. 2020 [cited 2022 Apr 1];10. Available from: /pmc/articles/PMC6965178/.
- Sanford B, Holinka LG, O’Donnell V, et al. Deletion of the thymidine kinase gene induces complete attenuation of the Georgia isolate of African swine fever virus. Virus Res [Internet]. 2016;213:165–171. [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/26656424/.
- Moore DM, Zsak L, Neilan JG, et al. The African Swine Fever Virus Thymidine Kinase Gene Is Required for Efficient Replication in Swine Macrophages and for Virulence in Swine. J Virol [Internet]. 1998;72:10310, [cited 2022 Apr 1]; Available from: /pmc/articles/PMC110620/.
- Neilan JG, Zsak L, Lu Z, et al. Novel swine virulence determinant in the left variable region of the African swine fever virus genome. J Virol [Internet]. 2002;76:3095–3104. [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/11884534/.
- Abrams CC, Goatley L, Fishbourne E, et al. Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus. Virol [Internet]. 2013;443:99, [cited 2022 Apr 1]; Available from: /pmc/articles/PMC3709090/.
- Gallardo C, Sánchez EG, Pérez-Núñez D, et al. African swine fever virus (ASFV) protection mediated by NH/P68 and NH/P68 recombinant live-attenuated viruses. Vaccine [Internet]. 2018;36:2694–2704. [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/29609966/.
- Gladue DP, O’Donnell V, Ramirez-Medina E, et al. Deletion of CD2-Like (CD2v) and C-Type Lectin-Like (EP153R) Genes from African Swine Fever Virus Georgia-Δ9GL Abrogates Its Effectiveness as an Experimental Vaccine. Viruses. 2020;12.
- O’Donnell V, Holinka LG, Sanford B, et al. African swine fever virus Georgia isolate harboring deletions of 9GL and MGF360/505 genes is highly attenuated in swine but does not confer protection against parental virus challenge. Virus Res [Internet]. 2016;221:8–14. [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/27182007/.
- Ramirez-Medina E, Vuono E, O’Donnell V, et al. Differential Effect of the Deletion of African Swine Fever Virus Virulence-Associated Genes in the Induction of Attenuation of the Highly Virulent Georgia Strain. Viruses [Internet]. 2019;11, [cited 2022 Apr 1]; Available from: https://pubmed.ncbi.nlm.nih.gov/31269702/.
- O’Donnell V, Risatti GR, Holinka LG, et al. Simultaneous Deletion of the 9GL and UK Genes from the African Swine Fever Virus Georgia 2007 Isolate Offers Increased Safety and Protection against Homologous Challenge. Perlman S, editor. J Virol [Internet]. 2017;91:e01760–16. Available from: http://jvi.asm.org/content/91/1/e01760-16.abstract.
- Chen W, Zhao D, He X, et al. A seven-gene-deleted African swine fever virus is safe and effective as a live attenuated vaccine in pigs. Science China Life Sciences [Internet]. 2020;63:623, [cited 2022 Mar 21]; Available from: /pmc/articles/PMC7223596/.
- Borca MV, Ramirez-Medina E, Silva E, et al. Development of a Highly Effective African Swine Fever Virus Vaccine by Deletion of the I177L Gene Results in Sterile Immunity against the Current Epidemic Eurasia Strain. J Virol [Internet]. 2020;94, [cited 2022 Mar 21]; Available from: /pmc/articles/PMC7081903/.
- Borca MV, Ramirez-Medina E, Silva E, et al. ASFV-G-ΔI177L as an Effective Oral Nasal Vaccine against the Eurasia Strain of Africa Swine Fever. Viruses [Internet]. 2021;13, [cited 2022 Apr 5]; Available from: https://pubmed.ncbi.nlm.nih.gov/33925435/.
- Tran XH, Le TTP, Nguyen QH, et al. African swine fever virus vaccine candidate ASFV-G-ΔI177L efficiently protects European and native pig breeds against circulating Vietnamese field strain. Transboundary Emerging Dis [Internet]. 2021 [cited 2022 Apr 5]; Available from: https://onlinelibrary.wiley.com/doi/full/10.1111tbed.14329.
- Vietnam steps closer to African swine fever vaccine [Internet]. [cited 2022 Apr 5]. Available from: https://vir.com.vn/vietnam-steps-closer-to-african-swine-fever-vaccine-91504.html.
- Borca MV, Rai A, Ramirez-Medina E, et al. A Cell Culture-Adapted Vaccine Virus against the Current African Swine Fever Virus Pandemic Strain. J Virol [Internet]. 2021;95, [cited 2022 Mar 21]; Available from: /pmc/articles/PMC8315737/.
- Velazquez-Salinas L, Ramirez-Medina E, Rai A, et al. Development Real-Time PCR Assays to Genetically Differentiate Vaccinated Pigs From Infected Pigs With the Eurasian Strain of African Swine Fever Virus. Front Vet Sci. 2021;8:1247.
- VACDIVA. Periodic Reporting for period 1 - VACDIVA (A safe DIVA vaccine for African Swine Fever control and eradication) | H2020 | CORDIS | European Commission [Internet]. CORDIS EU research results. 2021 [cited 2022 Apr 6]. Available from: https://cordis.europa.eu/project/id/862874/reporting.
- Barasona JA, Cadenas-Fernández E, Kosowska A, et al. Safety of African Swine Fever Vaccine Candidate Lv17/WB/Rie1 in Wild Boar: Overdose and Repeated Doses. Front Immunol [Internet]. 2021;12, [cited 2022 Apr 6]; Available from: https://pubmed.ncbi.nlm.nih.gov/34917082/.
- Teklue T, Wang T, Luo Y, et al. Generation and Evaluation of an African Swine Fever Virus Mutant with Deletion of the CD2v and UK Genes. Vaccines (Basel) [Internet]. 2020;8:1–17. [cited 2022 Mar 21]; Available from: /pmc/articles/PMC7768475/.
- Zhang Y, Ke J, Zhang J, et al. African Swine Fever Virus Bearing an I226R Gene Deletion Elicits Robust Immunity in Pigs to African Swine Fever. J Virol [Internet]. 2021;95, [cited 2022 Mar 21]; Available from: /pmc/articles/PMC8577359/.
- Gladue DP, Ramirez-Medina E, Vuono E, et al. Deletion of the A137R Gene from the Pandemic Strain of African Swine Fever Virus Attenuates the Strain and Offers Protection against the Virulent Pandemic Virus. J Virol [Internet]. 2021;95, [cited 2022 Mar 21] Available from: https://pubmed.ncbi.nlm.nih.gov/34406865/.
- Faburay B. Genome Plasticity of African Swine Fever Virus: Implications for Diagnostics and Live-Attenuated Vaccines. Pathogens. 2022;11:145, [Internet]. 2022 [cited 2022 Apr 8];11:145. Available from: https://www.mdpi.com/2076-0817/11/2/145/htm.
- FAO. ASF situation in Asia & Pacific update [Internet]. FAO ASF situation update - African Swine Fever (ASF) - FAO Emergency Prevention System for Animal Health (EMPRES-AH). 2021 [cited 2022 Apr 8]. Available from: https://www.fao.org/ag/againfo/programmes/en/empres/ASF/situation_update.html.
- Li L, Ren Z, Wang Q, et al. Infection of African swine fever in wild boar, China, 2018. Transboundary Emerging Dis [Internet]. 2019;66:1395–1398. doi:10.1111/tbed.13114.
- Murtaugh MP, Yuan S, Nelson EA, et al. Genetic interaction between porcine reproductive and respiratory syndrome virus (PRRSV) strains in cell culture and in animals. J Swine Health Prod [Internet]. 2002;1:15–21. [cited 2022 Mar 21]; Available from: https://www.aasv.org/jshap/issues/v10n1/v10n1p15.html.
- Portugal R, Goatley LC, Husmann R, et al. A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus. Emerging Microbes Infect [Internet]. 2020;9:1245, [cited 2022 Apr 8]; Available from: /pmc/articles/PMC7448849/.